FDA Expected to Approve New COVID-19 Vaccine Amid Rising Cases

Updated vaccines will target recent variants, with availability anticipated in the coming weeks.

Current vaccines are in short supply as pharmacies await updated versions.
New vaccines from Pfizer, Moderna, and Novavax will target the KP.2 strain and its variants.
Experts recommend high-risk individuals get vaccinated as soon as the new shots are available.
Timing of vaccination is crucial for optimal protection through the winter season.
Costs for the new vaccines will be covered by most insurance plans, but uninsured adults may face challenges.